Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of -12.27 is 23877% below its 3-year average of -0.05, near the high end of its 3-year range (-81.08–1.53).
As of the fiscal period ended Tuesday, June 30, 2026. 33.29% above its 12-month average of -18.39.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): -12.27.
DEBT TO EQUITY RATIO
-12.27
DEBT TO EQUITY RATIO AVG TTM
-18.39
DEBT TO EQUITY RATIO AVG 3Y
-0.05
DEBT TO EQUITY RATIO AVG 5Y
N/A
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+33.29%
CURRENT VS 3Y AVG
-23876.75%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.12
median of 648 covered companies
CURRENT VS SECTOR MEDIAN
-10323.58%
vs the sector median at left
Medicus Pharma Ltd. Common Stock
Market Cap
$10.06M
Debt to Equity Ratio
-12.27
TTM Avg
-18.39
3Y Avg
-0.05
5Y Avg
N/A
Market Cap
$10.10M
Debt to Equity Ratio
0.02
TTM Avg
0.18
3Y Avg
0.10
5Y Avg
0.18
Market Cap
$10.44M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$10.68M
Debt to Equity Ratio
0.00
TTM Avg
0.03
3Y Avg
0.03
5Y Avg
0.03
Market Cap
$11.00M
Debt to Equity Ratio
0.09
TTM Avg
0.06
3Y Avg
1.84
5Y Avg
2.48
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medicus Pharma Ltd. Common Stock (MDCX) | $10.06M | -12.27 | -18.39 | -0.05 | N/A |
| MetaVia Inc. (MTVA)vs › | $10.08M | 0.03 | 0.03 | 0.02 | 0.01 |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $10.10M | 0.02 | 0.18 | 0.10 | 0.18 |
| Lifeward Ltd. (LFWD)vs › | $9.92M | 0.91 | 0.29 | 0.15 | 0.12 |
| Ainos, Inc. (AIMD)vs › | $9.76M | 4.21 | 1.11 | 0.63 | 0.57 |
| Satellos Bioscience Inc. (MSLE)vs › | $10.44M | 0.00 | 0.00 | 0.00 | 0.00 |
| Polyrizon Ltd. (PLRZ)vs › | $10.64M | 0.00 | 0.00 | 0.88 | 0.58 |
| Caring Brands, Inc. (CABR)vs › | $10.68M | 0.00 | 0.03 | 0.03 | 0.03 |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.00M | 0.09 | 0.06 | 1.84 | 2.48 |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.29M | 0.00 | 0.05 | 0.05 | 0.05 |
Debt/Equity
-12.27
Current Ratio
1.57
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | -12.27 |
| 2026-03-31 | 0.13 |
| 2025-12-31 | -81.08 |
| 2025-09-30 | -0.26 |
| 2025-06-30 | 1.53 |
| 2025-03-31 | 0.14 |
| 2024-12-31 | 0.10 |
| 2024-09-30 | 0.10 |
| 2024-06-30 | 0.06 |
| 2024-03-31 | -0.60 |
| 2023-12-31 | 0.00 |
| 2023-09-30 | 0.00 |
| 2023-06-30 | -0.18 |
